CRO

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials. Download this new guide from SGS to discover: How to collaborate in the fast-paced […]

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials. Download this SGS guide to discover: How to collaborate in the fast-paced world of […]

This is the latest episode of the free narrated DDW podcast, “CROs and targeted protein degradation offer an exciting future”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “CROs: Drug discovery expertise on hand” and “Why the emergence of targeted protein degradation is so exciting”. […]

Challenges in outsourcing drug discovery In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring.   The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time. Many companies have several projects ongoing simultaneously, […]

Clinical research organisation (CRO) Celerion has been recognised for its contributions to the industry by claiming an award for the seventh consecutive year.   The company was named  recipient of the Life Science Leader and Clinical Leader’s CRO Leadership Awards in all five award categories. The awards recognise the CRO in five categories: capabilities, compatibility, expertise, quality, and reliability in […]

The CRO market has seen tremendous growth in the last 10 years, undergoing significant changes in terms of remote trials, smaller patient populations, as well as the more recent pandemic pressures.   The drug pipeline is also now larger than ever and CROs have increased their strategic importance to innovators – particularly smaller and virtual biotechs. […]

Contract research organisation (CRO) Cellomatics Biosciences has appointed a new senior director to help it expand. The company has hired Anand Krishna as senior director to help oversee customer care and management, sales, operations, and marketing. Krishna has over 25 years of executive leadership and field sales management experience in companies ranging from VC-funded dotcom start-ups, […]

Learn how to reduce your clinical study budget by 45-55% in Central and Eastern Europe by downloading this Whitepaper by Research Professionals CRO. This whitepaper identifies the most significant cost elements of a typical clinical study budget and breaks it down so you can maximize your cost savings when you partner with a leading CRO in Central […]

Listen to this article on the DDW Podcast: Lu Rahman asks Laura Hinton, Operations Director at Gentronix, to offer some insight into the contract research organisation (CRO) market and how Gentronix is making its presence known in this sector.  Gentronix is a specialist contract research organisation (CRO) based in the UK, focused on delivering predictive toxicology products and services to global chemical sectors. Gentronix offers a portfolio of […]

Gentronix, a UK-based contract research organisation (CRO) working in the field of genetic toxicology, has raised £700,000 in a funding round led by existing investor Mercia to support its continued growth.  The latest round, which includes a number of private investors, follows Gentronix’s recent acquisition of the Big Blue transgenic mutation assay from Merck KGaA. It will be used […]

Discover how Central and Eastern Europe (CEE) provides an attractive environment to conduct clinical studies of any phase while partnered with a local CRO in this interview with Research Professionals’ Managing Partner, György Barta (DPharm).  Barta discusses the many benefits of conducting clinical studies in CEE as well how Research Professionals, a leading CRO with […]

Medicine developer CatSci has collaborated with the Cambridge Crystallographic Data Centre (CCDC). CatSci’s experimental expertise in material science combined with CCDC’s informatics tools will offer an integrated solution to customers, adding strategic value from molecule to medicine.  CCDC’s informatics-based services apply big data learnings from over one million published crystal structures to better understand solid forms, which will help to guide CatSci’s experimental […]

Nottingham, UK-based contract research organisation (CRO) Cellomatics Biosciences has reported year-on-year organic revenue growth of 30% since its inception in 2015, as demand for its preclinical and early discovery phase laboratory services and expertise continues to increase.   Based at BioCity Nottingham, Cellomatics is a specialist preclinical CRO with expertise in five main therapeutic areas: oncology, immuno-oncology, immunology, inflammation and respiratory. Despite the challenges […]

Aurelia Bioscience, a Nottingham, UK based pre-clinical Contract Research Organisation (CRO) has produced a new video to explain the functioning of WES and JESS – two highly reproducible, capillary based, automated western blot instruments from ProteinSimple: Whilst traditional western blotting typically runs 10-20 samples in three to five hours and requires 24-48 hours to produce […]

Domainex has been awarded ‘Best CRO’ at the OBN Awards 2020. Dr Tom Mander, CEO, Dr Ray Boffey, Executive Director of Medicines Research, and Dr Cat Stace, Director of Business Development, attended the postponed awards ceremony in London on June 11, 2021. Domainex has invested in new technology to support its clients’ research needs and […]

Increasingly, pharma companies are looking for a one-stop-shop when outsourcing clinical research support. Outsourcing without focusing on safety, however, is turning out to be a costly decision for some companies, leading to mistakes and budget overrun. Natalia Vlcek, Pharmacovigilance Manager and EU QPPV at Arriello Group, contends that it is time that safety became a […]